Stratec SE (0RAR.L)
EUR 23.02
(-0.04%)
EUR 23.02
(-0.04%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 41.95 Million EUR | 8.97% |
| 2022 | 36.74 Million EUR | -1.4% |
| 2021 | 37.26 Million EUR | 6.67% |
| 2020 | 34.93 Million EUR | 9.68% |
| 2019 | 31.84 Million EUR | -15.81% |
| 2018 | 37.82 Million EUR | -2.14% |
| 2017 | 38.65 Million EUR | 3.27% |
| 2016 | 37.43 Million EUR | 32.94% |
| 2015 | 28.15 Million EUR | 34.83% |
| 2014 | 20.88 Million EUR | -6.23% |
| 2013 | 22.27 Million EUR | 1.45% |
| 2012 | 21.95 Million EUR | -46.59% |
| 2011 | 41.1 Million EUR | 14.05% |
| 2010 | 36.03 Million EUR | 22.14% |
| 2009 | 29.5 Million EUR | 485.07% |
| 2008 | 5.04 Million EUR | 465.17% |
| 2007 | -1.38 Million EUR | 8.3% |
| 2006 | -1.5 Million EUR | -118.68% |
| 2005 | 8.06 Million EUR | 5.55% |
| 2004 | 7.63 Million EUR | 172.85% |
| 2003 | -10.48 Million EUR | -30.36% |
| 2002 | -8.04 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 11.73 Million EUR | -1.6% |
| 2024 Q3 | 13.06 Million EUR | 11.28% |
| 2024 Q1 | 11.92 Million EUR | 9.46% |
| 2023 Q2 | 10.74 Million EUR | 3.56% |
| 2023 Q1 | 10.37 Million EUR | 17.72% |
| 2023 FY | 40.03 Million EUR | 8.97% |
| 2023 Q4 | 10.89 Million EUR | 13.77% |
| 2023 Q3 | 9.57 Million EUR | -10.9% |
| 2022 Q3 | 9.42 Million EUR | -5.68% |
| 2022 FY | 36.74 Million EUR | -1.4% |
| 2022 Q4 | 8.81 Million EUR | -6.41% |
| 2022 Q1 | 8.51 Million EUR | -14.77% |
| 2022 Q2 | 9.98 Million EUR | 17.3% |
| 2021 Q2 | 9.99 Million EUR | 15.75% |
| 2021 FY | 37.26 Million EUR | 6.67% |
| 2021 Q3 | 8.64 Million EUR | -13.51% |
| 2021 Q1 | 8.63 Million EUR | 53.88% |
| 2021 Q4 | 9.99 Million EUR | 15.58% |
| 2020 Q3 | 9.96 Million EUR | 20.38% |
| 2020 FY | 34.93 Million EUR | 9.68% |
| 2020 Q4 | 5.61 Million EUR | -43.72% |
| 2020 Q1 | 11.07 Million EUR | 126.84% |
| 2020 Q2 | 8.28 Million EUR | -25.21% |
| 2019 Q3 | 9.06 Million EUR | 2.28% |
| 2019 Q2 | 8.86 Million EUR | -2.02% |
| 2019 FY | 31.84 Million EUR | -15.81% |
| 2019 Q4 | 4.88 Million EUR | -46.14% |
| 2019 Q1 | 9.04 Million EUR | 41.98% |
| 2018 FY | 37.82 Million EUR | -2.14% |
| 2018 Q1 | 9.49 Million EUR | 57.35% |
| 2018 Q2 | 10.09 Million EUR | 6.28% |
| 2018 Q3 | 10.72 Million EUR | 6.28% |
| 2018 Q4 | 6.37 Million EUR | -40.61% |
| 2017 Q4 | 6.03 Million EUR | -34.19% |
| 2017 Q3 | 9.17 Million EUR | -21.66% |
| 2017 Q2 | 11.7 Million EUR | -0.35% |
| 2017 Q1 | 11.74 Million EUR | 260.2% |
| 2017 FY | 38.65 Million EUR | 3.27% |
| 2016 Q1 | 6.36 Million EUR | -17.98% |
| 2016 FY | 37.43 Million EUR | 32.94% |
| 2016 Q2 | 13.52 Million EUR | 112.33% |
| 2016 Q3 | 14.27 Million EUR | 5.59% |
| 2016 Q4 | 3.26 Million EUR | -77.16% |
| 2015 Q1 | 6.57 Million EUR | 203.74% |
| 2015 FY | 28.15 Million EUR | 34.83% |
| 2015 Q4 | 7.76 Million EUR | 12.49% |
| 2015 Q3 | 6.9 Million EUR | -0.1% |
| 2015 Q2 | 6.91 Million EUR | 5.03% |
| 2014 Q2 | 5.44 Million EUR | -20.63% |
| 2014 Q3 | 6.4 Million EUR | 17.64% |
| 2014 FY | 20.88 Million EUR | -6.23% |
| 2014 Q1 | 6.86 Million EUR | 3.42% |
| 2014 Q4 | 2.16 Million EUR | -66.2% |
| 2013 Q3 | 4.39 Million EUR | -21.34% |
| 2013 Q1 | 5.65 Million EUR | 148.27% |
| 2013 Q2 | 5.58 Million EUR | -1.27% |
| 2013 FY | 22.27 Million EUR | 1.45% |
| 2013 Q4 | 6.63 Million EUR | 51.06% |
| 2012 Q3 | 11.01 Million EUR | -2.24% |
| 2012 Q1 | 10.65 Million EUR | -3.69% |
| 2012 Q2 | 11.27 Million EUR | 5.78% |
| 2012 Q4 | -11.72 Million EUR | -206.37% |
| 2012 FY | 21.95 Million EUR | -46.59% |
| 2011 FY | 41.1 Million EUR | 14.05% |
| 2011 Q2 | 10.12 Million EUR | 5.54% |
| 2011 Q4 | 11.06 Million EUR | 11.99% |
| 2011 Q3 | 9.87 Million EUR | -2.48% |
| 2011 Q1 | 9.59 Million EUR | -64.11% |
| 2010 Q3 | 9.29 Million EUR | 3.31% |
| 2010 FY | 36.03 Million EUR | 22.14% |
| 2010 Q4 | 26.74 Million EUR | 187.71% |
| 2010 Q1 | 7.96 Million EUR | -63.55% |
| 2010 Q2 | 8.99 Million EUR | 12.9% |
| 2009 Q3 | -6.16 Million EUR | -185.05% |
| 2009 Q2 | 7.24 Million EUR | 10.39% |
| 2009 Q4 | 21.86 Million EUR | 454.86% |
| 2009 FY | 29.5 Million EUR | 485.07% |
| 2009 Q1 | 6.56 Million EUR | 0.0% |
| 2008 FY | 5.04 Million EUR | 465.17% |
| 2007 FY | -1.38 Million EUR | 8.3% |
| 2006 FY | -1.5 Million EUR | -118.68% |
| 2005 FY | 8.06 Million EUR | 5.55% |
| 2004 FY | 7.63 Million EUR | 172.85% |
| 2003 FY | -10.48 Million EUR | -30.36% |
| 2002 FY | -8.04 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cegedim SA | 235.64 Million EUR | 82.195% |
| Guerbet SA | 550.79 Million EUR | 92.382% |
| Nexus AG | 44.98 Million EUR | 6.731% |
| Bastide Le Confort Médical SA | 1.91 Million EUR | -2092.111% |
| Revenio Group Oyj | 18.8 Million EUR | -123.176% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 96.744% |
| Sartorius Aktiengesellschaft | 1.02 Billion EUR | 95.897% |
| LNA Santé SA | 178.1 Million EUR | 76.443% |
| Siemens Healthineers AG | 5.59 Billion EUR | 99.251% |
| Medios AG | 23.03 Million EUR | -82.145% |
| Equasens Société anonyme | 14.67 Million EUR | -186.005% |